In an aluminum chloride (AlCl₃)-induced rat neurodegeneration model, four weeks of aerobic, resistance, or combined exercise produced modality-specific improvements in cognitive and behavioral outcomes. Resistance exercise delivered the greatest gains in recognition memory and forelimb grip strength alongside elevated circulating irisin. Aerobic exercise most effectively reduced anxiety-like behavior and raised brain-derived neurotrophic factor (BDNF). Combined exercise improved outcomes across all measured domains, with biomarker profiles reflecting each modality's distinct signaling signature.
This finding matters because it moves the field beyond the blanket prescription of 'exercise is neuroprotective' toward mechanistic specificity — a necessary step for clinical translation. The irisin-resistance and BDNF-aerobic dissociation aligns with emerging human data showing that myokine release is load- and contraction-type dependent, not simply a consequence of caloric expenditure. For aging adults at risk of cognitive decline, this suggests that combining modalities is not redundant but biochemically complementary, engaging parallel neuroprotective axes simultaneously. That said, the study's limitations are substantial: AlCl₃ toxicity is a contested proxy for Alzheimer's pathology, the cohort is exclusively male rats, the intervention lasted only four weeks, and circulating biomarkers don't confirm blood-brain barrier penetration or hippocampal target engagement. Translating myokine dose-response relationships from rodents to humans is notoriously unreliable. Incremental but directionally important — the mechanistic granularity here strengthens the case for future human trials stratifying exercise type by cognitive versus anxiety endpoints.
